- Recent Funding
- Investors
- Paragon Biosciences
Paragon Biosciences portfolio
Paragon Biosciences has 1 portfolio company on record at Recent Funding.
About this page
It led 1 of the 2 rounds it joined. Its most recent investment on record is Emalex Biosciences's $250M Series B+ round in November 2022, alongside Fidelity, Bain Capital Life Sciences and Valor Equity Partners. That company is in Health and bio. It has co-invested with Valor Equity Partners, Fidelity and Bain Capital Life Sciences, most often Valor Equity Partners (2 rounds).
What Paragon Biosciences invests in
- Health and bio · 1 · 100%
How Paragon Biosciences invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 2 100% | $285M |
Paragon Biosciences portfolio companies
EEmalex Biosciences$250MSeries B+ · Nov 2022
| Company | Round with Paragon Biosciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $250M | $285M | Nov 3, 2022 Series B+ |
Most frequent co-investors
VValor Equity Partners2 shared rounds · last Nov 3, 2022
FFidelity2 shared rounds · last Nov 3, 2022
BBain Capital Life Sciences1 shared round · last Nov 3, 2022
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 2 rounds on Recent Funding that name Paragon Biosciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Paragon Biosciences, which is a subset of its real portfolio. API: /api/v1/investors/paragon-biosciences (get a free API key). More: the most active VC firms and new venture capital funds.